CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-10 | FRIEDMAN PAUL A Director | Option exercise 10b5-1 | +24,800 | $15.80 | $392K | 211,964 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −624 | $547.75 | $342K | 211,340 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −535 | $548.51 | $293K | 210,805 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −409 | $549.99 | $225K | 210,396 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −4,316 | $550.93 | $2.4M | 206,080 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −7,193 | $551.67 | $4.0M | 198,887 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −5,533 | $552.74 | $3.1M | 193,354 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −5,001 | $553.83 | $2.8M | 188,353 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −1,029 | $555.00 | $571K | 187,324 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −160 | $555.39 | $89K | 187,164 |
| 2025-12-10 | FRIEDMAN PAUL A Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,800 | 24,800 | ||
| 2025-12-10 | Taub Rebecca Director | Option exercise 10b5-1 | +18,650 | $15.80 | $295K | 479,694 |
| 2025-12-10 | Taub Rebecca Director | Sale 10b5-1 | −491 | $547.76 | $269K | 479,203 |
| 2025-12-10 | Taub Rebecca Director | Sale 10b5-1 | −369 | $548.56 | $202K | 478,834 |
| 2025-12-10 | Taub Rebecca Director | Sale 10b5-1 | −486 | $550.07 | $267K | 478,348 |
| 2025-12-10 | Taub Rebecca Director | Sale 10b5-1 | −4,723 | $550.99 | $2.6M | 473,625 |
| 2025-12-10 | Taub Rebecca Director | Sale 10b5-1 | −4,410 | $551.85 | $2.4M | 469,215 |
| 2025-12-10 | Taub Rebecca Director | Sale 10b5-1 | −3,857 | $552.81 | $2.1M | 465,358 |
| 2025-12-10 | Taub Rebecca Director | Sale 10b5-1 | −3,087 | $553.88 | $1.7M | 462,271 |
| 2025-12-10 | Taub Rebecca Director | Sale 10b5-1 | −1,027 | $554.84 | $570K | 461,244 |
Page 10 of 82 · 1,629 trades